{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06309992",
            "orgStudyIdInfo": {
                "id": "1404-0056"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-505303-23-00",
                    "type": "REGISTRY",
                    "domain": "CTIS"
                },
                {
                    "id": "U1111-1299-9925",
                    "type": "REGISTRY",
                    "domain": "WHO registry"
                }
            ],
            "organization": {
                "fullName": "Boehringer Ingelheim",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight",
            "officialTitle": "Multicenter, Randomised, Double-blind, Placebo-controlled, 48-week, Phase III Trial to Evaluate the Efficacy and Safety of Survodutide Administered Subcutaneously in Participants With Overweight or Obesity and Presumed or Confirmed Nonalcoholic Steatohepatitis (NASH)",
            "therapeuticArea": [
                "Endocrinology",
                "Gastroenterology"
            ],
            "study": "a-study-to-test-whether-survodutide-helps-people-living-with-obesity-or-overweight-and-with-a-confirmed-or-presumed-liver-disease-called-non-alcoholic-steatohepatitis-nash-to-reduce-liver-fat-and-to-lose-weight"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-02-16",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-08",
            "studyFirstSubmitQcDate": "2024-03-08",
            "studyFirstPostDateStruct": {
                "date": "2024-03-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Boehringer Ingelheim",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is open to adults who are at least 18 years old and have\n\n* presumed or confirmed NASH together with overweight or obesity and\n* a body mass index (BMI) of 30 kg/m\u00b2 or more, or\n* a BMI of 27 kg/m\u00b2 and at least one weight-related health problem.\n\nPeople with a history of other chronic liver diseases cannot take part in this study.\n\nThe purpose of this study is to find out whether a medicine called survodutide helps people living with obesity or overweight and a confirmed or presumed liver disease called nonalcoholic steatohepatitis (NASH) to have less liver fat and to lose weight. Participants are put into 2 groups randomly, which means by chance. 1 group gets different doses of survodutide and 1 group gets placebo. Placebo looks like survodutide but does not contain any medicine. Every participant has a 2 in 3 chance of getting survodutide. Participants and doctors do not know who is in which group. Participants inject survodutide or placebo under their skin once a week for about 1 year. In addition to the study medicine, all participants receive counselling to make changes to their diet and to exercise regularly.\n\nParticipants are in the study for about 1 year and 3 months. During this time, it is planned that participants visit the study site up to 13 times and receive 3 phone calls by the site staff. The doctors check participants' health and take note of any unwanted effects. The participants' body weight is regularly measured. At 3 of the visits, the participants' liver is measured using different imaging methods. The results are compared between the groups to see whether the treatment works."
        },
        "conditionsModule": {
            "conditions": [
                "Obesity",
                "Non-Alcoholic SteatoHepatitis (NASH)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 160,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment arm",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Survodutide"
                    ]
                },
                {
                    "label": "Placebo arm",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Survodutide",
                    "description": "Survodutide",
                    "armGroupLabels": [
                        "Treatment arm"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo matching survodutide",
                    "armGroupLabels": [
                        "Placebo arm"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Relative reduction in liver fat content of at least 30% from baseline to Week 48 (yes/no) assessed by magnetic resonance imaging proton density fat fraction (MRI-PDFF)",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Relative change (%) in body weight from baseline to Week 48",
                    "timeFrame": "at baseline, at week 48"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Absolute change (%) from baseline to Week 48 in liver fat content assessed by MRI-PDFF",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Relative change (%) from baseline to Week 48 in liver fat content assessed by MRI-PDFF",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Reduction from baseline to Week 48 in Iron corrected T1 (cT1) levels of \u226580 ms (yes/no)",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Absolute change from baseline to Week 48 in alanine amino transferase (ALT) levels",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Relative change from baseline to Week 48 in alanine amino transferase (ALT) levels",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Absolute change from baseline to Week 48 in waist circumference [cm]",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Relative change from baseline to Week 48 in waist circumference [cm]",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Absolute change from baseline to Week 48 in Homeostasis Model Assessment -Insulin Resistance (HOMA-IR) (Fasting Plasma Insulin (FPI) [mlU/L] \u00b7 Fasting Plasma Glucose (FPG) [mmol/L]/22.5)",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Absolute change from baseline to Week 48 in liver stiffness assessed by magnetic resonance elastography (MRE)",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Relative change from baseline to Week 48 in liver stiffness assessed by magnetic resonance elastography (MRE)",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Absolute change in liver volume [mL] from baseline to Week 48 measured using MRI",
                    "timeFrame": "at baseline, at week 48"
                },
                {
                    "measure": "Relative change in liver volume [mL] from baseline to Week 48 measured using MRI",
                    "timeFrame": "at baseline, at week 48"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key inclusion criteria:\n\n* Male or female, age \u226518 years at the time of signing informed consent, and at least the legal age of consent in countries where it is \\>18 years\n* BMI \u226530 kg/m\u00b2, OR BMI \u226527 kg/m\u00b2 and at least one of the following weight-related comorbidities at screening:\n\n  * Hypertension (defined as repeated, i.e. at least 3 measurements in resting condition, Systolic Blood Pressure (SBP) values of \u2265140 mmHg and/or Diastolic Blood Pressure (DBP) values of \u226590 mmHg in the absence of anti-hypertensive treatment, or intake of at least 1 antihypertensive drug to maintain a normotensive blood pressure)\n  * Dyslipidaemia (defined as at least 1 lipid-lowering treatment required to maintain normal blood lipid levels, or lowdensity lipoprotein \\[LDL\\] \u2265160 mg/dL \\[\u22654.1 mmol/L\\] or triglycerides \u2265150 mg/dL \\[\u22651.7 mmol/L\\], or high-density lipoprotein (HDL\\] \\<40 mg/dL (\\<1.0 mmol/L\\] for men or HDL\\<50 mg/dL (\\<1.3 mmol/L) for women\n  * Obstructive sleep apnoea\n  * Cardiovascular disease (e.g. heart failure with New York Heart Association (NYHA) functional class II-III, history of ischaemic or haemorrhagic stroke or cerebrovascular revascularisation procedure \\[e.g. carotid endarterectomy and/or stent\\], MI, coronary artery disease, or peripheral vascular disease)\n  * Type 2 diabetes mellitus (T2DM) (diagnosed at least 180 days prior to screening, with glycated haemoglobin \\[HbA1c\\] \u22656.5% \\[48 mmol/mol\\] and \\<10% \\[86 mmol/mol\\] as measured by the central laboratory at screening)\n* History of at least one self-reported unsuccessful dietary effort to lose body weight Further inclusion criteria apply.\n\nKey exclusion criteria:\n\n* Current or history of significant alcohol consumption (defined as intake of \\>210 g/week in men and \\>140 g/week in women on average over a consecutive period of more than 3 months) or inability to reliably quantify alcohol consumption based on the investigator's judgement within the last 5 years.\n* Intake of medications associated with liver injury, hepatic steatosis or steatohepatitis.\n* History of other chronic liver diseases (e.g. viral hepatitis, autoimmune liver disease, primary biliary cholangitis , primary sclerosing cholangitis, Wilson's disease, hemochromatosis, Alpha-1 Antitrypsin (A1At) deficiency, history of liver transplantation). Hepatitis B and C testing will be done at Visit 1. Participants with positive hepatitis B surface antigen (HBsAg) should be excluded. Participants treated for hepatitis C must have a negative ribonucleic acid (RNA) test at screening and also be Hepatitis C virus (HCV) RNA negative for at least 3 years prior to screening in order to be eligible for the trial.\n* Cirrhosis based on clinical assessment, abdominal imaging, liver histology or non-invasive tests assessed at screening (enhanced liver fibrosis (ELF) \u226511.3 or Fibrosis (FIB)-4 \u22653.48 or FibroScan\u00ae VCTE\u2122 \u226520 kPa or MRE \u22654.68 kPa)\n* Current decompensated liver disease or previous hepatic decompensation (ascites, spontaneous bacterial peritonitis, portal hypertension bleeding, hepatic encephalopathy, hepatorenal syndrome).\n* Evidence of portal hypertension (e.g. splenomegaly, oesophageal varices, or other portosystemic collateral pathways).\n\nFurther exclusion criteria apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Boehringer Ingelheim",
                    "role": "CONTACT",
                    "phone": "1-800-243-0127",
                    "email": "clintriage.rdg@boehringer-ingelheim.com"
                }
            ],
            "locations": [
                {
                    "facility": "Ark Clinical Research",
                    "status": "RECRUITING",
                    "city": "Fountain Valley",
                    "state": "California",
                    "zip": "92708",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.70918,
                        "lon": -117.95367
                    }
                },
                {
                    "facility": "Velocity Clinical Research",
                    "status": "RECRUITING",
                    "city": "Gardena",
                    "state": "California",
                    "zip": "90247",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.88835,
                        "lon": -118.30896
                    }
                },
                {
                    "facility": "Ark Clinical Research",
                    "status": "RECRUITING",
                    "city": "Long Beach",
                    "state": "California",
                    "zip": "92657",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.76696,
                        "lon": -118.18923
                    }
                },
                {
                    "facility": "Velocity Clinical Research",
                    "status": "RECRUITING",
                    "city": "Panorama City",
                    "state": "California",
                    "zip": "91402",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.22473,
                        "lon": -118.44981
                    }
                },
                {
                    "facility": "Excel Medical Clinical Trials",
                    "status": "RECRUITING",
                    "city": "Boca Raton",
                    "state": "Florida",
                    "zip": "33434",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.3669,
                        "lon": -80.13033
                    }
                },
                {
                    "facility": "Bruce A. Segal, MD, PA",
                    "status": "RECRUITING",
                    "city": "Delray Beach",
                    "state": "Florida",
                    "zip": "33484",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.46146,
                        "lon": -80.07282
                    }
                },
                {
                    "facility": "Fleming Island Center for Clinical Research",
                    "status": "RECRUITING",
                    "city": "Fleming Island",
                    "state": "Florida",
                    "zip": "32003",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.0933,
                        "lon": -81.71898
                    }
                },
                {
                    "facility": "Covenant Metabolic Specialists, LLC",
                    "status": "RECRUITING",
                    "city": "Fort Myers",
                    "state": "Florida",
                    "zip": "33912",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.62168,
                        "lon": -81.84059
                    }
                },
                {
                    "facility": "Velocity Clinical Research",
                    "status": "RECRUITING",
                    "city": "Hallandale Beach",
                    "state": "Florida",
                    "zip": "33009",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.9812,
                        "lon": -80.14838
                    }
                },
                {
                    "facility": "Health Awareness, Inc.",
                    "status": "RECRUITING",
                    "city": "Jupiter",
                    "state": "Florida",
                    "zip": "33458",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.93422,
                        "lon": -80.09421
                    }
                },
                {
                    "facility": "Panax Clinical Research",
                    "status": "RECRUITING",
                    "city": "Miami Lakes",
                    "state": "Florida",
                    "zip": "33014",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.90871,
                        "lon": -80.30866
                    }
                },
                {
                    "facility": "Verus Clinical Research Corporation",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33135",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Covenant Research and Clinics, LLC",
                    "status": "RECRUITING",
                    "city": "Sarasota",
                    "state": "Florida",
                    "zip": "34240",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.33643,
                        "lon": -82.53065
                    }
                },
                {
                    "facility": "Springfield Clinic, LLP",
                    "status": "RECRUITING",
                    "city": "Springfield",
                    "state": "Illinois",
                    "zip": "62702",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.80172,
                        "lon": -89.64371
                    }
                },
                {
                    "facility": "Kansas Medical Center",
                    "status": "RECRUITING",
                    "city": "Topeka",
                    "state": "Kansas",
                    "zip": "66606",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.04833,
                        "lon": -95.67804
                    }
                },
                {
                    "facility": "Louisiana Research Center, LLC",
                    "status": "RECRUITING",
                    "city": "Shreveport",
                    "state": "Louisiana",
                    "zip": "71105",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.52515,
                        "lon": -93.75018
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Velocity Clinical Research, Austin",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78759",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "Amel Med LLC",
                    "status": "RECRUITING",
                    "city": "Georgetown",
                    "state": "Texas",
                    "zip": "78628",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.63269,
                        "lon": -97.67723
                    }
                },
                {
                    "facility": "Biopharma Informatic, Inc. Research Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77084",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Clinical Trials of Texas, LLC",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Impact Research Institute",
                    "status": "RECRUITING",
                    "city": "Waco",
                    "state": "Texas",
                    "zip": "76710",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.54933,
                        "lon": -97.14667
                    }
                },
                {
                    "facility": "GI Select Health Research LLC",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23236",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Boehringer Ingelheim",
                            "role": "CONTACT",
                            "phone": "833-602-2368",
                            "email": "unitedstates@bitrialsupport.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Related Info",
                    "url": "https://www.mystudywindow.com"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Once the criteria in section \"Time Frame\" are fulfilled, researchers can use the following link https://www.mystudywindow.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed \"Document Sharing Agreement\".\n\nFurthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "One year after the approval has been granted by major Regulatory Authorities and after the primary manuscript has been accepted for publication, or after termination of the development program.",
            "accessCriteria": "For study documents - upon signing of a 'Document Sharing Agreement'. For study data - 1. after the submission and approval of the research proposal (checks will be performed by the sponsor and/or the independent review panel, including checking that the planned analysis does not compete with sponsor's publication plan); 2. and upon signing of a legal agreement.",
            "url": "https://www.mystudywindow.com/msw/datasharing"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005234",
                    "term": "Fatty Liver"
                },
                {
                    "id": "D000065626",
                    "term": "Non-alcoholic Fatty Liver Disease"
                },
                {
                    "id": "D000009765",
                    "term": "Obesity"
                },
                {
                    "id": "D000050177",
                    "term": "Overweight"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                },
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8375",
                    "name": "Fatty Liver",
                    "asFound": "Steatohepatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                },
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "asFound": "Obesity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "asFound": "Overweight",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18102",
                    "name": "Weight Loss",
                    "relevance": "LOW"
                },
                {
                    "id": "M30540",
                    "name": "Non-alcoholic Fatty Liver Disease",
                    "asFound": "Non-alcoholic Steatohepatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5868",
                    "name": "Visceral Steatosis",
                    "asFound": "Steatohepatitis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M11110",
                    "name": "Liver Extracts",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}